Conclusively, our study suggests that the excretory-secretory and somatic products of S. obvelata, as well as their combination, can elevate the FOXP3/RORɣt ratio in PBMCs of IBD patients, indicating anti-inflammatory changes. The gene discussed is FOXP3; the disease is inflammatory bowel disease.